Why is GPT Healthcare falling/rising?

As of 02-Jul, GPT Healthcare Ltd is currently priced at Rs 142.15, reflecting a decline of Rs 2.4 or 1.66%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total drop of 3.37% during this period. Additionally, the stock has shown poor performance over the past week and month, with returns of -3.46% and -6.42%, respectively. Despite a high management efficiency indicated by a return on capital employed (ROCE) of 28.30% and a low debt-to-equity ratio, the stock's long-term growth prospects appear weak, with net sales and operating profit growth rates of only 13.80% and 15.20% over the last five years. This underperformance is compounded by a flat financial result in March 2025 and a significant decline in cash reserves.
Broader market context shows that GPT Healthcare has consistently underperformed against the benchmark, with a one-year return of -7.42% compared to the Sensex's gain of 5.00%. The stock's performance today has also lagged behind its sector by 0.91%. While there has been a notable increase in investor participation, with delivery volume rising by 162.32% against the five-day average, the overall sentiment remains negative due to the stock's failure to meet growth expectations and its continued decline relative to the broader market.